Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -54.04 K-174.74 K-338.04 K-1.28 M-189.86 K-1.35 M -3.16 M Non-Operating Income, Total 02.31 M3.71 M3.5 M3.2 M3.23 M 13.64 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 02.31 M3.71 M3.5 M3.2 M3.23 M 13.64 M Unusual income/expense —————— — Pretax income -54.04 K2.13 M3.37 M2.21 M3.01 M1.88 M 10.47 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -54.04 K-1.74 M1.84 M868.96 K6.15 M264.62 K 9.12 M Discontinued operations —————— — Net income -54.04 K-1.74 M1.84 M868.96 K6.15 M264.62 K 9.12 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -54.04 K-1.74 M1.84 M868.96 K6.15 M264.62 K 9.12 M Basic earnings per share (Basic EPS) -0.012.791.95-4.14-0.150.18 -2.16 Diluted earnings per share (Diluted EPS) -0.012.761.95-3.96-0.150.18 -1.98 Average basic shares outstanding 8.97 M19.54 M28.14 M32.41 M45.08 M45.08 M — Diluted shares outstanding 8.97 M20.34 M28.68 M32.41 M45.08 M45.08 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —